Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$3.85B |
| 2 |
Tesla
TSLA
|
+$1.78B |
| 3 |
Apple
AAPL
|
+$1.57B |
| 4 |
Alphabet (Google) Class A
GOOGL
|
+$1.49B |
| 5 |
Mastercard
MA
|
+$1.09B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Honeywell
HON
|
+$1.3B |
| 2 |
Phillips 66
PSX
|
+$650M |
| 3 |
iShares China Large-Cap ETF
FXI
|
+$475M |
| 4 |
State Street Materials Select Sector SPDR ETF
XLB
|
+$432M |
| 5 |
NRG Energy
NRG
|
+$387M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 17.59% |
| 2 | Financials | 9.21% |
| 3 | Consumer Discretionary | 7.33% |
| 4 | Healthcare | 5.59% |
| 5 | Communication Services | 5.25% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2226
Park National Corp
PRK
$3.75B
| $3.28M | ﹤0.01% |
21,649
-7,834
| -27% | -$1.29M |
|
2227
LXP Industrial Trust
LXP
$3.58B
| $3.28M | ﹤0.01% |
75,755
-30,392
| -29% | -$1.3M |
|
2228
Supernus Pharmaceuticals
SUPN
$2.74B
| $3.28M | ﹤0.01% |
100,010
-22,839
| -19% | -$809K |
|
2229
Seacoast Banking Corp of Florida
SBCF
$3.48B
| $3.27M | ﹤0.01% |
127,254
-49,718
| -28% | -$1.36M |
|
2230
Denali Therapeutics
DNLI
$3.97B
| $3.27M | ﹤0.01% |
240,648
-37,419
| -13% | -$717K |
|
|
SRDX
2231
DELISTED
Surmodics
SRDX
| $3.27M | ﹤0.01% |
107,070
-931
| -0.9% | -$31.3K |
|
2232
CALL
SGHC Ltd
SGHC
$6.65B
| $3.26M | ﹤0.01% |
+505,900
| New | +$3.63M |
|
|
DOCU
2233
PUT
DocuSign
DOCU
$12.2B
| $3.26M | ﹤0.01% |
+40,000
| New | +$3.5M |
|
2234
Zevra Therapeutics
ZVRA
$664M
| $3.26M | ﹤0.01% |
434,690
+145,002
| +50% | +$1.15M |
|
|
SAIL
2235
SailPoint Inc
SAIL
$11.3B
| $3.25M | ﹤0.01% |
+173,519
| New | +$3.78M |
|
2236
AZZ Inc
AZZ
$4.52B
| $3.25M | ﹤0.01% |
38,881
-14,521
| -27% | -$1.3M |
|
2237
OFG Bancorp
OFG
$2.26B
| $3.25M | ﹤0.01% |
81,144
-21,236
| -21% | -$890K |
|
2238
Viavi Solutions
VIAV
$10.6B
| $3.24M | ﹤0.01% |
289,978
-114,966
| -28% | -$1.28M |
|
2239
Fulgent Genetics
FLGT
$513M
| $3.24M | ﹤0.01% |
191,998
+11,601
| +6% | +$198K |
|
2240
Sonoco
SON
$5.77B
| $3.24M | ﹤0.01% |
68,617
-33,067
| -33% | -$1.56M |
|
2241
Bread Financial
BFH
$4.51B
| $3.23M | ﹤0.01% |
64,552
-23,144
| -26% | -$1.31M |
|
2242
HNI Corp
HNI
$3.56B
| $3.22M | ﹤0.01% |
72,554
-24,906
| -26% | -$1.18M |
|
|
RFIX
2243
Simplify Bond Bull ETF
RFIX
$43.9M
| $3.21M | ﹤0.01% |
+60,000
| New | +$3.13M |
|
|
NVO
2244
CALL
Novo Nordisk
NVO
$205B
| $3.21M | ﹤0.01% |
46,200
+35,500
| +332% | +$2.93M |
|
2245
CALL
American International
AIG
$39.8B
| $3.21M | ﹤0.01% |
+36,900
| New | +$2.87M |
|
2246
Evertec
EVTC
$1.91B
| $3.2M | ﹤0.01% |
87,093
-31,738
| -27% | -$1.1M |
|
2247
iShares TIPS Bond ETF
TIP
$14.7B
| $3.19M | ﹤0.01% |
28,683
| – | – |
|
2248
CALL
Core Scientific
CORZ
$6.36B
| $3.19M | ﹤0.01% |
440,100
+70,100
| +19% | +$798K |
|
2249
Lemonade
LMND
$4.1B
| $3.18M | ﹤0.01% |
101,293
-17,787
| -15% | -$612K |
|
|
PMT
2250
PennyMac Mortgage Investment
PMT
$828M
| $3.18M | ﹤0.01% |
216,958
+64,191
| +42% | +$879K |
|
Similar funds
Barclays's Q1 2025 Portfolio in Review
As of Q1 2025, Barclays held 5,710 positions worth $353B, down 1.2% from $357B the previous quarter. Its ten largest holdings account for 37% of the portfolio.
Barclays deployed $16.5B of net new capital in Q1 2025, opening 439 new positions and adding to 1,449 existing holdings. Its largest new stake was JPMorgan BetaBuilders USD High Yield Corporate Bond ETF: 318,453 shares worth $14.7M.
By sector, the portfolio is most concentrated in Technology at 18% of assets, down from 18% a quarter earlier, followed by Financials and Consumer Discretionary.
On the sell side, the largest reduction was Honeywell, an estimated $1.3B trimmed.
- Barclays's largest Q1 2025 buy was JPMorgan BetaBuilders USD High Yield Corporate Bond ETF: 318,453 shares worth $14.7M.
- Barclays added most to State Street SPDR S&P 500 ETF Trust in Q1 2025, an estimated $3.85B increase.
- Barclays's biggest Q1 2025 reduction was Honeywell, cutting an estimated $1.3B.
- Barclays fully exited Smartsheet Inc. in Q1 2025, selling an estimated $45.7M.
- Barclays's ten largest holdings make up 37% of its $353B portfolio in Q1 2025.
- Barclays opened 439 new positions and closed 470 in Q1 2025.
- Barclays's portfolio value fell 1.2% quarter-over-quarter to $353B.
Based on Barclays's 13F filing for Q1 2025, filed 15 May 2025.